FV-429, an inhibitor of hexokinase, strongly induced apoptosis in cancer cells by both inhibition of glycolysis via suppression of HKII and by impairing the mitochondrial function via interfering with the HKII-VDAC interaction, leading to activation of mitochondria-mediated apoptosis [2]. This evidence concerns the gene HK2 and cancer.